Newer Approaches for Analytical Method Validation of Anti Diabetic Agents: A Review
Year: 2024
Type: article
Abstract: Diabetes refers to a metabolic disorder identified by Hyperglycemia. Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) are also called as Gliptins are a relatively new class of antidiabetic drugs to treat type-2 diabetes. Analytical method development and validation play an indispensable role in analysis and manufacture of pharmaceuticals. The intent of this article is to study the reported analytical methods in the literature for assessment of Dipeptidyl peptidase- 4 inhibitors. This review covers divergent analytical methods for the estimation of these drugs. Many spectroscopic and chromatographic techniques are available for the determination and evaluation of these drugs in bulk and pharmaceutical preparation. Newly evolved and advanced chromatographic techniques are also available for the estimation of these drugs in biological fluids such as Liquid Chromatography- Tandem Mass Spectroscopy (LC- MS/MS), Gas Chromatography- Mass Spectroscopy (GC- MS), High Performance Liquid Chromatography- Mass Spectroscopy (HPLC-MS) and Ultra- Fast Liquid Chromatography (UFLC). The development and validation of analytical methods is imperative for drug development studies and even for the development of drug formulation including stability and degradation studies and also for the determination of pharmacokinetic data of these drugs. This review work summaries the current position of analytical methods for estimation of these antidiabetic drugs in bulk, dosage form and biological fluids.
Authors: Priyadarshini Chaudhari, Mayur Prajapati, Nidhi Patel, Dhruv Patel, Anjali Prajapati, Khushbu Patel
Language: English
Subfield: Analytical Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W6930887260
FWCI:
Cites:
Cited by:
Related to: